Target intelligence / Profile preview

Bilirubin metabolism

01

Overview

Bilirubin metabolism refers to the sequential degradation of heme (primarily from erythrocyte breakdown), producing biliverdin (via heme oxygenase), then bilirubin (via biliverdin reductase). Unconjugated bilirubin is insoluble and circulates bound to albumin. It is taken up by hepatocytes, conjugated with glucuronic acid (via UDP-glucuronosyltransferase, a family of enzymes), making it water-soluble. Conjugated bilirubin is excreted in bile and further metabolized by gut bacteria into colorless urobilinogen and then stercobilin, which are excreted in feces or reabsorbed and excreted in urine. Key steps are tightly regulated, as accumulation of bilirubin or its intermediates is toxic. Bilirubin metabolism is crucial for detoxification, prevention of oxidative damage (antioxidant effects), and diagnostic assessment of liver and hemolytic diseases[1][3][4][7]. In summary, "Bilirubin metabolism" is a metabolic pathway, not a discrete molecule or direct drug target. The pathway involves several enzymes (notably: heme oxygenase, biliverdin reductase, UDP-glucuronosyltransferase), transporters, and binding proteins.

02

Mechanism of action

Increase or decrease of conjugation (e.g., UDP-glucuronosyltransferase induction); Enhancement of excretion (e.g., bile acids); Structural modification for increased solubility (e.g., phototherapy alters unconjugated bilirubin)

03

Biological functions

Heme catabolismDetoxificationAntioxidant activityWaste elimination
04

Disease associations

JaundiceLiver dysfunctionHemolytic diseaseCardiovascular disease (via systemic effects)[2][4]Cancer (roles in tumor biology emerging)[6]
05

Safety considerations

Accumulation of unconjugated or conjugated bilirubin is toxic—elevated levels result in jaundice and risk of kernicterus in neonates[1]Altered metabolism in liver or hemolytic diseases can cause systemic toxicity
06

Interacting drugs

Phenobarbital (indirect, by inducing glucuronidation enzymes)

3 more in the full profile.

07

Biomarkers

Total serum bilirubinDirect (conjugated) bilirubinIndirect (unconjugated) bilirubin levelsUrinary urobilinogen

Beyond the preview

Go deeper on Bilirubin metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bilirubin metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call